Correction: Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study

Correction: Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study

Saved in:

Bibliographic Details
Main Authors:	Rongrong Wang, Tengteng Zhang, Han Wang, Yao Ren, Runze Zhao, Gaopan Zhang, Guoxun Zhang, Xiongfei Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Neurology
Subjects:	relapsing–remitting multiple sclerosis sleep disorders fatigue anxiety depression cognitive impairment
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1669440/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study
by: Rongrong Wang, et al.
Published: (2025-07-01)

Cognitive profile of patients with relapsing remitting multiple sclerosis
by: VIVIAN M. ANDRADE, et al.
Published: (1999-09-01)

Role of Diet and Supplementation with Omega-3 Polyunsaturated Fatty Acids for Managing Chronic Fatigue in Patients with Relapsing-Remitting Multiple Sclerosis
by: Nicholas Shepherd, et al.
Published: (2022-11-01)

Volumetric assessment of hypothalamus in relapsing–remitting multiple sclerosis
by: Sara Sameh AbdelRahman Abdallah, et al.
Published: (2025-07-01)

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients
by: Justyna Chojdak-Łukasiewicz, et al.
Published: (2025-06-01)

Fatigue and its correlation with anxiety and depression in patients with multiple sclerosis in China
by: Han Wang, et al.
Published: (2025-07-01)

Evaluation of the Efficacy, Safety, and Adherence to Oral Drug Therapy in Patients with Relapsing–Remitting Multiple Sclerosis
by: Paulius Sėdžius, et al.
Published: (2025-04-01)

Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning
by: Ziya EKŞİ, et al.

Altered intra- and interregional synchronization in relapsing&ndash;remitting multiple sclerosis: a resting-state fMRI study
by: Wu L, et al.
Published: (2016-04-01)

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-07-01)

Gadolinium deposition in the brain of patients with relapsing-remitting multiple sclerosis after 10 years of follow-up
by: Kostić Dejan, et al.
Published: (2023-01-01)

Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis
by: Rocío Gómez-Ballesteros, et al.
Published: (2025-07-01)

Progression independent of relapsing biology in multiple sclerosis: a real-word study
by: Heather Y. F. Yong, et al.
Published: (2025-05-01)

The impact of changing diagnostic criteria on disability in a Brazilian multiple sclerosis cohort
by: Felipe Toscano Lins de Menezes, et al.
Published: (2025-06-01)

Multiple Sclerosis Disease-Modifying Treatment Algorithms: 2025 Positioning of the Portuguese Multiple Sclerosis Study Group
by: Carlos Capela, et al.
Published: (2025-05-01)

Esclerose múltipla: estudo de pacientes com a forma surto-remissão cadastrados na Secretaria de Estado da Saúde de Minas Gerais Multiple sclerosis: study of patients with relapsing-remitting form registered at Minas Gerais Secretary State for Health
by: Eustáquio Claret dos Santos, et al.
Published: (2007-09-01)

Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra
by: A. A. Sokolova, et al.
Published: (2024-06-01)

Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review
by: John L. Petrie, et al.
Published: (2024-10-01)

Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study
by: José Eustasio Meca-Lallana, et al.
Published: (2024-12-01)

Serum YKL-40 levels in patients with multiple sclerosis
by: Ahmet Dönder, et al.
Published: (2021-10-01)

Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple Sclerosis
by: Barrero Hernández FJ, et al.
Published: (2025-03-01)

Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review
by: D. L. Klabukova, et al.
Published: (2018-11-01)

Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN Study
by: Patrick Vermersch, et al.
Published: (2025-04-01)

Correspondence of MRI and nTMS With EDSS in Multiple Sclerosis: Longitudinal Follow‐Up Study
by: Antonia Bralić, et al.
Published: (2025-06-01)

Profile of Ofatumumab in the Treatment of Multiple Sclerosis: Design, Development and Place in Therapy
by: Awada Z, et al.
Published: (2024-12-01)

Fadiga na forma remitente recorrente da esclerose múltipla Fatigue in multiple sclerosis relapsing-remitting form
by: MARIA FERNANDA MENDES, et al.
Published: (2000-06-01)

Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis
by: Douglas Martins Braga, et al.
Published: (2016-06-01)

Motor symptoms and the quality of life of relapsing-remitting multiple sclerosis patients in a specialized center in South of Brazil
by: Francielle Fontana Jorge, et al.
Published: (2021-01-01)

Mental health outcomes in pregnant women with relapsing-remitting multiple sclerosis: a longitudinal cohort study
by: Lena Kristina Pfeffer, et al.
Published: (2025-07-01)

Natalizumab-associated progressive multifocal leukoencephalopathy
by: Trevor Glenn, et al.
Published: (2025-06-01)

Sustainable Business Models and IT Innovation: The Case of the REMIT
by: Svitlana Kolosok, et al.
Published: (2022-09-01)

Serum neurofilament heavy chains as a biomarker of neuronal damage in multiple sclerosis relapse
by: P. Beliaziūnas, et al.
Published: (2021-03-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)

Triggers for multiple sclerosis relapse in Saudi Arabia: An exploratory cross-sectional study
by: Foziah J. Alshamrani, et al.
Published: (2025-04-01)

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis
by: Eman M. Khedr, et al.
Published: (2025-04-01)

Assessing female sexual dysfunction in patients with relapsing-remitting multiple sclerosis
by: Elisa Matias Vieira de Melo, et al.
Published: (2025-04-01)

Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis
by: Izadora Nogueira Fonte Boa, et al.

Incidence of multiple sclerosis (MS) relapse after COVID-19 infection: A systematic review and meta-analysis
by: Amin Momeni Moghadam, et al.
Published: (2025-03-01)

Long-Term Management and Therapeutic Sequencing for Patients with Relapsing Multiple Sclerosis in France: A Vignette Study
by: Patrick Vermersch, et al.
Published: (2025-03-01)

Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs
by: Guilherme Diogo Silva, et al.
Published: (2025-09-01)